IECM
HCAT icon

Intrinsic Edge Capital Management’s Health Catalyst HCAT Stock Holding History

Intrinsic Edge Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-87,478
Closed -$659K – 165
2024
Q1 		$659K Buy
+87,478
New +$798K 0.05% 138

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Intrinsic Edge Capital Management's HCAT Position: Q2 2024 in Review

Intrinsic Edge Capital Management sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 87,478 shares — an estimated $659K sold.

Intrinsic Edge Capital Management first reported a position in HCAT in Q1 2024 and held it in 1 quarter. The position peaked at $659K in Q1 2024. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.

  • Intrinsic Edge Capital Management reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 87,478 Health Catalyst shares in Q2 2024, an estimated $659K.
  • Intrinsic Edge Capital Management first reported a position in Health Catalyst in Q1 2024 and held it in 1 quarter.
  • Intrinsic Edge Capital Management's Health Catalyst position peaked at $659K in Q1 2024.
  • 161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.

Based on Intrinsic Edge Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.